Torthaí cuardaigh - Massimo Di Maïo

Beachtaigh na torthaí
  1. 1
    Quality of Life in elderly patients with cancer.

    Quality of Life in elderly patients with cancer. de réir Massimo Di Maïo, Federica Perrone

    Foilsithe / Cruthaithe 2003
    Faigh an téacs iomlán Faigh an téacs iomlán
    Revisão
    Cuir le mo chuid Ceanán
    Sábháilte in:
  2. 2
    Platinum-based chemotherapy in advanced non-small-cell lung cancer: optimal number of treatment cycles

    Platinum-based chemotherapy in advanced non-small-cell lung cancer: optimal number of treatment cycles de réir Antônio Rossi, Massimo Di Maïo

    Foilsithe / Cruthaithe 2016
    Faigh an téacs iomlán
    Revisão
    Cuir le mo chuid Ceanán
    Sábháilte in:
  3. 3
    A review of guidelines for lung cancer

    A review of guidelines for lung cancer de réir Paolo Bironzo, Massimo Di Maïo

    Foilsithe / Cruthaithe 2018
    Faigh an téacs iomlán Faigh an téacs iomlán
    Revisão
    Cuir le mo chuid Ceanán
    Sábháilte in:
  4. 4
    Association Between Health-Related Quality of Life Measures and Survival Endpoints in Oncology Clinical Trials and in Clinical Decision Making: A Narrative Review

    Association Between Health-Related Quality of Life Measures and Survival Endpoints in Oncology Clinical Trials and in Clinical Decision Making: A Narrative Review de réir Anna Amela Valsecchi, Massimo Di Maïo

    Foilsithe / Cruthaithe 2025
    Faigh an téacs iomlán
    Revisão
    Cuir le mo chuid Ceanán
    Sábháilte in:
  5. 5
    Real-World Evidence in Oncology: Opportunities and Limitations

    Real-World Evidence in Oncology: Opportunities and Limitations de réir Massimo Di Maïo, Francesco Perrone, Pierfranco Conté

    Foilsithe / Cruthaithe 2019
    Faigh an téacs iomlán Faigh an téacs iomlán
    Artigo
    Cuir le mo chuid Ceanán
    Sábháilte in:
  6. 6
    Adding PD-1/PD-L1 Inhibitors to Chemotherapy for the First-Line Treatment of Extensive Stage Small Cell Lung Cancer (SCLC): A Meta-Analysis of Randomized Trials

    Adding PD-1/PD-L1 Inhibitors to Chemotherapy for the First-Line Treatment of Extensive Stage Small Cell Lung Cancer (SCLC): A Meta-Analysis of Randomized Trials de réir Francesco Facchinetti, Massimo Di Maïo, Marcello Tiseo

    Foilsithe / Cruthaithe 2020
    Faigh an téacs iomlán Faigh an téacs iomlán
    Revisão
    Cuir le mo chuid Ceanán
    Sábháilte in:
  7. 7
    A meta-analysis of the impact of bronchial stump coverage on the risk of bronchopleural fistula after pneumonectomy

    A meta-analysis of the impact of bronchial stump coverage on the risk of bronchopleural fistula after pneumonectomy de réir Massimo Di Maïo, Federica Perrone, Claude Deschamps, Gaetano Rocco

    Foilsithe / Cruthaithe 2014
    Faigh an téacs iomlán Faigh an téacs iomlán
    Revisão
    Cuir le mo chuid Ceanán
    Sábháilte in:
  8. 8
    COVID-19 Emergency and the Need to Speed Up the Adoption of Electronic Patient-Reported Outcomes in Cancer Clinical Practice

    COVID-19 Emergency and the Need to Speed Up the Adoption of Electronic Patient-Reported Outcomes in Cancer Clinical Practice de réir Laura Marandino, Andrea Necchi, Massimo Aglietta, Massimo Di Maïo

    Foilsithe / Cruthaithe 2020
    Faigh an téacs iomlán
    Editorial
    Cuir le mo chuid Ceanán
    Sábháilte in:
  9. 9
    Papillary renal cell carcinoma: A review of the current therapeutic landscape

    Papillary renal cell carcinoma: A review of the current therapeutic landscape de réir Giulia Courthod, Marcello Tucci, Massimo Di Maïo, Giorgio V. Scagliotti

    Foilsithe / Cruthaithe 2015
    Faigh an téacs iomlán
    Revisão
    Cuir le mo chuid Ceanán
    Sábháilte in:
  10. 10
    Chemotherapy in Combination With Immune Checkpoint Inhibitors for the First-Line Treatment of Patients With Advanced Non-small Cell Lung Cancer: A Systematic Review and Literature-Based Meta-Analysis

    Chemotherapy in Combination With Immune Checkpoint Inhibitors for the First-Line Treatment of Patients With Advanced Non-small Cell Lung Cancer: A Systematic Review and Literature-... de réir Alfredo Addeo, Giuseppe Luigi Banna, Giulio Metro, Massimo Di Maïo

    Foilsithe / Cruthaithe 2019
    Faigh an téacs iomlán Faigh an téacs iomlán
    Revisão
    Cuir le mo chuid Ceanán
    Sábháilte in:
  11. 11
    Tyrosine Kinase Inhibitors of Vascular Endothelial Growth Factor Receptors in Clinical Trials: Current Status and Future Directions

    Tyrosine Kinase Inhibitors of Vascular Endothelial Growth Factor Receptors in Clinical Trials: Current Status and Future Directions de réir Alessandro Morabito, Ermelinda De Maio, Massimo Di Maïo, Nicola Normanno, Federica Perrone

    Foilsithe / Cruthaithe 2006
    Faigh an téacs iomlán Faigh an téacs iomlán
    Revisão
    Cuir le mo chuid Ceanán
    Sábháilte in:
  12. 12
    Molecular biomarkers to predict response to neoadjuvant chemotherapy for bladder cancer

    Molecular biomarkers to predict response to neoadjuvant chemotherapy for bladder cancer de réir Consuelo Buttigliero, Marcello Tucci, Francesca Vignani, Giorgio V. Scagliotti, Massimo Di Maïo

    Foilsithe / Cruthaithe 2017
    Faigh an téacs iomlán
    Revisão
    Cuir le mo chuid Ceanán
    Sábháilte in:
  13. 13
    Skeletal metastases and impact of anticancer and bone-targeted agents in patients with castration-resistant prostate cancer

    Skeletal metastases and impact of anticancer and bone-targeted agents in patients with castration-resistant prostate cancer de réir Francesca Vignani, Valentina Bertaglia, Consuelo Buttigliero, Marcello Tucci, Giorgio V. Scagliotti, Massimo Di Maïo

    Foilsithe / Cruthaithe 2016
    Faigh an téacs iomlán
    Revisão
    Cuir le mo chuid Ceanán
    Sábháilte in:
  14. 14
    Enzalutamide-resistant castration-resistant prostate cancer: challenges and solutions

    Enzalutamide-resistant castration-resistant prostate cancer: challenges and solutions de réir Marcello Tucci, Clizia Zichi, Consuelo Buttigliero, Francesca Vignani, Giorgio V. Scagliotti, Massimo Di Maïo

    Foilsithe / Cruthaithe 2018
    Faigh an téacs iomlán Faigh an téacs iomlán
    Revisão
    Cuir le mo chuid Ceanán
    Sábháilte in:
  15. 15
    Tackling ALK in non-small cell lung cancer: the role of novel inhibitors

    Tackling ALK in non-small cell lung cancer: the role of novel inhibitors de réir Francesco Facchinetti, Marcello Tiseo, Massimo Di Maïo, Paolo Graziano, Emilio Bria, Giulio Rossi, Silvia Novello

    Foilsithe / Cruthaithe 2016
    Faigh an téacs iomlán
    Revisão
    Cuir le mo chuid Ceanán
    Sábháilte in:
  16. 16
    Understanding and overcoming the mechanisms of primary and acquired resistance to abiraterone and enzalutamide in castration resistant prostate cancer

    Understanding and overcoming the mechanisms of primary and acquired resistance to abiraterone and enzalutamide in castration resistant prostate cancer de réir Consuelo Buttigliero, Marcello Tucci, Valentina Bertaglia, Francesca Vignani, Paolo Bironzo, Massimo Di Maïo, Giorgio V. Scagliotti

    Foilsithe / Cruthaithe 2015
    Faigh an téacs iomlán
    Revisão
    Cuir le mo chuid Ceanán
    Sábháilte in:
  17. 17
    Neuroendocrine breast carcinoma: a rare but challenging entity

    Neuroendocrine breast carcinoma: a rare but challenging entity de réir Elena Trevisi, Anna La Salvia, Lorenzo Daniele, Maria Pia Brizzi, Gaetano De Rosa, Giorgio V. Scagliotti, Massimo Di Maïo

    Foilsithe / Cruthaithe 2020
    Faigh an téacs iomlán Faigh an téacs iomlán
    Revisão
    Cuir le mo chuid Ceanán
    Sábháilte in:
  18. 18
    Is flexible bronchoscopy necessary to confirm the position of double-lumen tubes before thoracic surgery?☆

    Is flexible bronchoscopy necessary to confirm the position of double-lumen tubes before thoracic surgery?☆ de réir Mario De Bellis, Rosanna Accardo, Massimo Di Maïo, Carmine Lamanna, Giovanni Battista Rossi, Maria Caterina Pace, Vincenzo Romano, Gaetano Rocco

    Foilsithe / Cruthaithe 2011
    Faigh an téacs iomlán
    Artigo
    Cuir le mo chuid Ceanán
    Sábháilte in:
  19. 19
    Individual Patient Data Meta-Analysis of Docetaxel Administered Once Every 3 Weeks Compared With Once Every Week Second-Line Treatment of Advanced Non–Small-Cell Lung Cancer

    Individual Patient Data Meta-Analysis of Docetaxel Administered Once Every 3 Weeks Compared With Once Every Week Second-Line Treatment of Advanced Non–Small-Cell Lung Cancer de réir Massimo Di Maïo, Francesco Perrone, Paolo Chiodini, Ciro Gallo, Carlos Camps, Wolfgang Schuette, Élisabeth Quoix, Chun-Ming Tsai, Cesare Gridelli

    Foilsithe / Cruthaithe 2007
    Faigh an téacs iomlán
    Revisão
    Cuir le mo chuid Ceanán
    Sábháilte in:
  20. 20
    Implications of KRAS mutations in acquired resistance to treatment in NSCLC

    Implications of KRAS mutations in acquired resistance to treatment in NSCLC de réir Marzia Del Re, Eleonora Rofi, Giuliana Restante, Stefania Crucitta, E. Arrigoni, Stefano Fogli, Massimo Di Maïo, Iacopo Petrini, Romano Danesi

    Foilsithe / Cruthaithe 2017
    Faigh an téacs iomlán Faigh an téacs iomlán
    Revisão
    Cuir le mo chuid Ceanán
    Sábháilte in:

Uirlisí cuardaigh: